Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Boytsov · SciRah

Researcher profile · Semantic Scholar

N. Boytsov

Share profile

N. Boytsov — researcher profile on SciRah

h-index: 13
Works: 78
Citations: 1,243

Most-cited papers

Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014
T. Hunter, N. Boytsov, Xiang Zhang, K. Schroeder +2 more
2017Rheumatology International406 citations
Semantic Scholar
Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
D. Solomon, Stephen S. Johnston, N. Boytsov, D. Mcmorrow +2 more
2014Journal of Bone and Mineral Research368 citations Open access
Semantic Scholar
Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
A. Keshishian, N. Boytsov, R. Burge, K. Krohn +4 more
2017Journal of Managed Care & Specialty Pharmacy50 citations Open access
Semantic Scholar
Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study
P. F. Wang, C. Yee, B. Gorsh, M. Zichlin +8 more
2022Leukemia and Lymphoma33 citations Open access
Semantic Scholar
Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population
A. Keshishian, N. Boytsov, R. Burge, K. Krohn +4 more
2017Osteoporosis International32 citations Open access
Semantic Scholar
The direct and indirect costs of adult atopic dermatitis
J. Manjelievskaia, N. Boytsov, M. Brouillette, U. Onyekwere +3 more
2021Journal of Managed Care & Specialty Pharmacy27 citations Open access
Semantic Scholar
Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat‐to‐Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology
H. Yun, Lang Chen, F. Xie, H. Patel +3 more
2020Arthritis care & research26 citations
Semantic Scholar
Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis
N. Boytsov, Xiang Zhang, K. Evans, Barbara H. Johnson
2019PharmacoEconomics - Open23 citations Open access
Semantic Scholar
Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population
D. Kern, L. Chang, K. Sonawane, C. Larmore +6 more
2018Rheumatology and Therapy23 citations Open access
Semantic Scholar
Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis
M. Grabner, N. Boytsov, Qing Huang, Xiang Zhang +2 more
2017Arthritis Research & Therapy21 citations Open access
Semantic Scholar
Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis.
Joseph Yang, N. Boytsov, J. Carlson, D. Barthold
2023Journal of Managed Care & Specialty Pharmacy17 citations Open access
Semantic Scholar
The Effectiveness of a Private Orthopaedic Practice-Based Osteoporosis Management Service to Reduce the Risk of Subsequent Fractures
D. Sietsema, A. Araújo, Li Wang, N. Boytsov +6 more
2018Journal of Bone and Joint Surgery. American volume16 citations
Semantic Scholar
Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USA.
A. Ribbands, N. Boytsov, A. Bailey, B. Gorsh +2 more
2023Future Oncology14 citations Open access
Semantic Scholar
Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment.
L. Batchelder, S. Philpott, V. Divino, N. Boytsov +5 more
2022Future Oncology13 citations Open access
Semantic Scholar
A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods
E. Pierce, N. Boytsov, Joe Vasey, T. Sudaria +4 more
2021Dermatologic Therapy12 citations Open access
Semantic Scholar
Osteoporotic fractures and associated hospitalizations among patients treated with teriparatide compared to a matched cohort of patients not treated with teriparatide
N. Boytsov, Xiang Zhang, T. Sugihara, Kathleen A. Taylor +1 more
2015Current Medical Research and Opinion12 citations
Semantic Scholar
Real-world patient-reported outcomes and concordance between patient and physician reporting of side effects across lines of therapy in multiple myeloma within the USA
A. Ribbands, N. Boytsov, A. Bailey, B. Gorsh +2 more
2023Supportive Care in Cancer11 citations Open access
Semantic Scholar
US health care utilization and costs in adult patients with atopic dermatitis by disease severity
Xin Wang, N. Boytsov, M. Gorritz, W. Malatestinic +2 more
2022Journal of Managed Care & Specialty Pharmacy11 citations Open access
Semantic Scholar
Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims
Christopher Fenske, N. Boytsov, Jiaying Guo, Z. Dawson
2022Advances in Therapy11 citations Open access
Semantic Scholar
Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
N. Boytsov, R. Bhattacharya, K. Saverno, L. Dixon +4 more
2019Journal of Managed Care & Specialty Pharmacy11 citations Open access
Semantic Scholar
“A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis”
Xiang Zhang, Douglas Faries, N. Boytsov, J. Stamey +1 more
2016Pharmacoepidemiology and Drug Safety11 citations
Semantic Scholar
The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study
N. Boytsov, M. Gorritz, Xin Wang, W. Malatestinic +2 more
2021Journal of dermatological treatment (Print)10 citations Open access
Semantic Scholar
A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA
Elizabeth Wehler, N. Boytsov, C. Nicolay, O. Herrera-Restrepo +1 more
2019PharmacoEconomics (Auckland)9 citations Open access
Semantic Scholar
Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study
M. Hultcrantz, D. Kleinman, R. Vij, F. Escalante +13 more
2022Blood8 citations Open access
Semantic Scholar
Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients
N. Boytsov, L. Harrold, M. Mason, C. Gaich +4 more
2016Current Medical Research and Opinion8 citations
Semantic Scholar
Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review
F. Gay, E. Zamagni, C. Cole, C. Scheid +9 more
2025Frontiers in Oncology7 citations Open access
Semantic Scholar
Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
Lu-Lu Lee, A. Goren, N. Boytsov, C. Donatucci +1 more
2016Patient Preference and Adherence7 citations Open access
Semantic Scholar
Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States
M. Hultcrantz, D. Kleinman, Ravi Vij, Fernando Escalante +13 more
2024Haematologica6 citations Open access
Semantic Scholar
Multiple myeloma care, treatment patterns, and treatment durations in academic and community care settings
N. Boytsov, Catherine B. McGuiness, Zi-Fan Zhou, T. Huo +3 more
2025Future Oncology5 citations Open access
Semantic Scholar
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy
M. Gorritz, N. Boytsov, O. Goldblum, W. Malatestinic +2 more
2021Journal of dermatological treatment (Print)5 citations Open access
Semantic Scholar
CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature
S. McNamara, J. Chorazy, A. Pandey, J. Bitetti +3 more
2024Value in Health4 citations
Semantic Scholar
Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study
C. Larmore, N. Boytsov, C. Gaich, Xiang Zhang +5 more
2018Rheumatology and Therapy4 citations Open access
Semantic Scholar
Impact of social determinants of health on treatment patterns and outcomes in multiple myeloma
N. Boytsov, J. Multani, Zi-Fan Zhou, N. Kotowsky +5 more
2025Future Oncology3 citations Open access
Semantic Scholar
Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta‐Analysis
Joshua Richter, A. Nooka, P. Rodríguez-Otero, F. Schjesvold +10 more
2025American journal of hematology/oncology3 citations Open access
Semantic Scholar
PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE
M. Hultcrantz, D. Kleinman, R. Vij, F. Escalante +13 more
2023HemaSphere2 citations Open access
Semantic Scholar
Treatment Patterns and Patient Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Stratified By Exposure to Lenalidomide or Anti-CD38 Therapy and Double-Class Refractory Status: A Retrospective Electronic Health Record Database Study
J. Richter, P. F. Wang, A. Molinari, B. Gorsh +10 more
2022Blood2 citations Open access
Semantic Scholar
Real-World Assessment of Prior Treatment Patterns in Patients Receiving Belantamab Mafodotin Using a Longitudinal Pharmacy and Medical Open Source Claims Database
N. Boytsov, K. Stockl, Chi-Chang Chen, Feng Wang +4 more
2021Blood2 citations Open access
Semantic Scholar
Physician decision-making on use of treatments for relapsed/refractory multiple myeloma (RRMM) in later lines: What drives preferences?
L. Batchelder, S. Philpott, V. Divino, N. Boytsov +5 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
Treatment Patterns and Outcomes of Patients with Double-Class Refractory or Triple-Class Refractory Multiple Myeloma: A Retrospective US Electronic Health Record Database Study
Feng Wang, B. Gorsh, M. DerSarkissian, P. Paka +9 more
2021Blood2 citations Open access
Semantic Scholar
Patient and Provider Characteristics Associated With Optimal Post-Fracture Osteoporosis Management
N. Boytsov, A. Crawford, L. Hazel-Fernandez, J. McAna +4 more
2017American Journal of Medical Quality2 citations
Semantic Scholar
HSD57 Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) on Second and Third Line (2L/3L) Therapy, Classified By Urbanicity and Ethnicity
A. Molinari, N. Boytsov, J. Tkacz, P.-F. Wang +4 more
2023Value in Health1 citations
Semantic Scholar
The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World
A. Suvannasankha, Thomas W. Leblanc, Julia R. Correll, Chloe Carmichael +16 more
2022Blood1 citations Open access
Semantic Scholar
Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials
C. McGuiness, N. Boytsov, Xiang Zhang, Xin Wang +2 more
2021Rheumatology and Therapy1 citations Open access
Semantic Scholar
Current Clinical Practice and Decision-Making in Multiple Myeloma Treatment in the United States of America: A Real-World Survey
A. Ribbands, B. Gorsh, A. Bailey, N. Boytsov +3 more
2021Blood1 citations Open access
Semantic Scholar
EE154 IMPACT OF USING RELATIVE DOSE INTENSITY VERSUS INDIVIDUAL PATIENT DOSING: A CASE STUDY USING BELANTAMAB MAFODOTIN DATA FROM THE DREAMM-7 STUDY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Yevgeniy Samyshkin, M. Purser, Alex Bates, N. Boytsov +4 more
2026Value in Health0 citations
Semantic Scholar
Gaps in access to chimeric antigen receptor T-cell (CAR-T) therapy post leukapheresis: Waiting time and post-leukapheresis treatment patterns in relapsed/refractory multiple myeloma (RRMM)—Real-world evidence from U.S. claims.
S. Ailawadhi, N. Boytsov, J. Multani, Zi-Fan Zhou +5 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Comparative efficacy of belantamab mafodotin plus bortezomib and dexamethasone (BVd) vs standard of care in patients with relapsed/refractory multiple myeloma (RRMM).
Joshua Richter, P. Shukla, V. Kapetanakis, Molly Purser +3 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
EE264 BUDGET IMPACT MODEL (BIM) OF BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE (BVD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE UNITED STATES (US)
N. Boytsov, M. Purser, Richard Zur, Yevgeniy Samyshkin +6 more
2026Value in Health0 citations
Semantic Scholar
Comparative Efficacy of Belantamab Mafodotin in Combination With Bortezomib and Dexamethasone Versus Standards of Care in Patients With Third‐Line or Later Relapsed/Refractory Multiple Myeloma
Joshua Richter, Yvonne A. Efebera, H. Yimer, P. Shukla +4 more
2026American journal of hematology/oncology0 citations Open access
Semantic Scholar
Indirect treatment comparison of belantamab mafodotin + pomalidomide + dexamethasone versus comparator regimens in lenalidomide-exposed relapsed/refractory multiple myeloma: A network meta-analysis
Joshua Richter, M. Beksaç, Alessandro Corso, Ollie Schofield +14 more
2025Blood0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Xiang Zhang×10
Invite
Xiang Zhang — researcher profile on SciRah
B. Gorsh×8
Invite
B. Gorsh — researcher profile on SciRah
M. Duh×6
Invite
M. Duh — researcher profile on SciRah
Molly Purser×6
Invite
Molly Purser — researcher profile on SciRah

×5

Invite

A. Araújo — researcher profile on SciRah

Invite

P. Paka — researcher profile on SciRah

Invite

O. Goldblum — researcher profile on SciRah

Invite

Xin Wang — researcher profile on SciRah

Invite

N. Kotowsky — researcher profile on SciRah

Invite

R. Wade — researcher profile on SciRah

M. Hultcrantz×4

Invite

M. Hultcrantz — researcher profile on SciRah

Invite

D. Kleinman — researcher profile on SciRah